Intrapace
Signal active
Organization
Contact Information
Overview
IntraPace® has developed a novel implantable system to treat obesity. It is built on the proven technology used in millions of cardiac pacemakers and defibrillators each year. The abiliti® system is designed to be implanted via standard laparoscopic instruments without making any changes to the anatomy of the digestive system or placing any limitations on what a person can eat or drink.
About
Industries
Biotechnology, Health Care, Health Diagnostics
Founded
2001
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Intrapace headquartered in United States, North America, operates in the Biotechnology, Health Care, Health Diagnostics sector. The company focuses on Biotechnology and has secured $16.2B in funding across 84 round(s). With a team of 11-50 employees, Intrapace is actively contributing to advancements in Biotechnology. Their latest funding round, Debt Financing - Intrapace, raised $624.0K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
7
Investors
0
Lead Investors
0
Total Funding Amount
$192.9M
Details
1
Intrapace has raised a total of $192.9M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2004 | Late Stage Venture | 14.6M |
Investors
Intrapace is funded by 10 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| CB Health Ventures | - | FUNDING ROUND - CB Health Ventures | 14.6M |
| The Halo Fund | - | FUNDING ROUND - The Halo Fund | 14.6M |
| Intrapace | - | FUNDING ROUND - Intrapace | 14.6M |
| Guidant | - | FUNDING ROUND - Guidant | 14.6M |
Recent Activity
There is no recent news or activity for this profile.